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that from 429 cases, the incidences of throat disease was 239 cases (55.97%), nose disease 163 cases (38.17%) and ear disease 25 cases (5.85%). From this study it can be concluded that the 10 most common ENT diseases, namely (1) acute pharyngitis, (2) epistaxis, (3) tonsillitis, (4) nasal polyps, (5) nasopharyngeal cancer, (6) benign neoplasm of connective or soft tissue of head, face, and neck, (7) laryngeal tumors, (8) tonsilopharyngitis, (9) laryngitis, and (10) sinusitis.4 Five of the 10 diseases are infectious diseases. The ears, nose and throat are anatomically close and histologically similar so the infection in these structures is usually caused by the same bacteria. Several studies have shown that 5 main causes of ENT diseases are Staphylococcus aureus, 
Abstract  Objective: To provide an overview of antibiotic use, bacterial patterns and sensitivity to antibiotics in the otolaryngology ward. 
 Methods: This was a cross-sectional study, with total sampling method from medical record data of otolaryngology inpatients that use antibiotics for the period of January 1, 2016–June 30, 2016. Exclusion criteria are incomplete patient medical records and chemotherapy or radiotherapy patients. The variables studied were antibiotic use, bacterial pattern and susceptibility.
 Results: Among 276 subjects included in the inclusion criteria, the most widely used are single antibiotics (98.9%), generally used for 2–3 days (73.9%), via intravenous lines (92%), and with indications as empirical+prophylaxis (77.5%). Commonly used antibiotics are cefazolin (42.51%), ceftriaxone (29.54%), and cefotaxime (20.76%). The most common bacteria were E. coli (36.36%) and the most sensitive types of antibiotics were meropenem, amikacin, and tigecyclin, while the most resistant antibiotics were ampicillin, 
ciprofloxacin, and ceftriaxone. 
 Conclusions: The majority of antibiotics used in the otolaryngology treatment room are cefazolin as prophylaxis. E. coli were the most found culture results and the most sensitive types of antibiotics, namely meropenem, amikacin, and 
tigecyclin, while the most resistant antibiotics were ampicillin, ciprofloxacin, and ceftriaxone.
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Introduction Ear, nose, and throat (ENT) disease have morbidity that can have a major effect on the life of the sufferer.1 For example, in patients 
with hearing loss can experience difficulties in communication.2 Choking or swallowing foreign objects if not handled properly and quickly can cause death due to asphyxia.3 A study that conducted at Department of ENT, Dr. R. D. Kandou Hospital, Manado, Indonesia about inpatient patterns in 2010-2012 showed 
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Streptococcus sp., Pseudomonas aeruginosa, 
Proteus sp., and Escherichia coli.5,6,7Antibiotics are one of the drugs that are often used in ENT wards, as a causative therapy in infectious diseases and prophylaxis in surgical procedures. In its use, administration of antibiotics must be in accordance with the diagnosis of the disease and the cause of the microorganism. Various studies state that around 40–62% of antibiotics are used inappropriately, for example it is used for diseases that do not actually require antibiotics. A previous study on the quality of antibiotic use in various parts of the hospital found 30% to 80% not based on indications. This can cause antibiotic resistance. Antibiotic resistance can have an impact on morbidity and mortality, it also has a negative economic and social impact.8Antibiotic resistance has now become a common problem in Indonesia such as in Bandung, Indonesia. Based on a study on bacterial pattern and their sensitivity in patients with the ventilator-associated pneumonia (VAP) in the Intensive Care Unit (ICU) of Dr. Hasan Sadikin General Hospital, Bandung, the most common bacteria that cause VAP are Acinetobacter baumannii (41.9%), Pseudomonas aeruginosa (18.6%), and Klebsiella pneumoniae (16.9%). From the results of the sensitivity test, the sensitivity of the bacteria to some antibiotics decreased and some showed signs of resistance.9 The purpose of this study was to provide an overview of antibiotic use, bacterial patterns and their sensitivity to antibiotics in ENT wards. The results of this study are expected to be a reference for the use of antibiotics for the Antimicrobial Prevention Program (PPRA) at Dr. Hasan Sadikin General Hospital, Bandung. 
MethodsThis was a descriptive study and conducted from August to November 2018. The study used a cross-sectional design using secondary data from the Inpatient Medical Record Installation at the Dr. Hasan Sadikin General Hospital, Bandung in the period January–June 2016. Inclusion criteria in this study were all medical record data of patients using antibiotics in ENT wards at Dr. Hasan Sadikin General Hospital, Bandung. Exclusion criteria were incomplete or missing medical records and patients with the primary diagnosis of chemotherapy or radiotherapy.Data was taken from the patient’s medical record by the total sampling method, and 
was processed using computerized software. Data collection were carried out after obtaining ethical approval number 429/UN6.KEP/EC/2018 issued by the Health Research Ethics Committee of the Faculty of Medicine, universitas Padjadjaran and obtaining a research permit issued by Dr. Hasan Sadikin General Hospital, Bandung (No. LB.02.01/X.2.2.1/14556/2018). Selected data would be analyzed and presented in table form to illustrate patterns of antibiotic use, bacterial patterns and their sensitivity to antibiotics.
ResultsBased on the list of names given by medical record installations, the number of ENT inpatients in the study period was 493 people, but there were 139 data that were not stored in the medical record installation, leaving the remaining 370 data. Among 370 data, 7 data were excluded because patients did not use antibiotics, and 71 data were excluded because patients had a primary diagnosis of chemotherapy and radiotherapy, leaving 276 data that met the inclusion criteria and were used in this study.The characteristics of ENT inpatients could be seen (Table 1). It revealed that the most frequently found age groups were adults with 160 patients (58%). 
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Table 1
Characteristic n %Age   <1 years old (infant) 0 0   1–<10 years old (child) 22 8   10–<20 years old (teenager) 53 19.2   20–60 years old (adult) 160 58   >60 years old (elderly) 41 14.9Gender   Male 161 58.3   Female 115 41.7Length of stay   1-3 days 90 32.6   4-6 days 120 43.4
   ≥ 7 days 66 24
Characteristics of ENT Inpatients 
(n=276)
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Table 2 
ICD Diagnosis n %C01 Malignant Neoplasm of Base of Tongue 2 0.72C02 Malignant Neoplasm of Other & Unspecified Parts of Tongue 3 1.09C05 Malignant Neoplasm of Palate 1 0.36C07 Malignant Neoplasm of Parotid Gland 1 0.36C09 Malignant Neoplasm of Tonsil 3 1.09C11 Malignant Neoplasm of Nasopharynx 7 2.54C13 Malignant Neoplasm of Hypopharynx 1 0.36C30 Malignant Neoplasm of Nasal Cavity & Middle Ear 10 3.62C31 Malignant Neoplasm of Accessory Sinuses 18 6.52C32 Malignant Neoplasm of Larynx 14 5.07C44 Other Unspecified Malignant Neoplasm of Skin 4 1.45C73 Malignant Neoplasm of Thyroid Gland 3 1.09C85 Other Specified & Unspecified Types of Non-Hodgkin Lymphoma 1 0.36D04 Carcinoma In Situ of Skin 1 0.36D10 Benign Neoplasm of Mouth and Pharynx 8 2.9D11 Benign Neoplasm of Major Salivary Gland 4 1.45D14 Benign Neoplasm of Middle Ear & Respiratory System 7 2.54D18 Hemangioma & Lymphangioma 3 1.09D21 Other Benign Neoplasm of Connective & Other Soft Tissue 1 0.36D34 Benign Neoplasm of Thyroid Gland 4 1.45D36 Benign Neoplasm of Other & Unspecified Sites 1 0.36
D37 Neoplasm of Uncertain Behaviour of Oral and Digestive Organs 2 0.72E04 Other Non-Toxic Goiter 1 0.36G47 Sleep Disorders 9 3.26H61 Other Disorders of External Ear 1 0.36H66 Suppurative and Unspecified Otitis Media 6 2.17H70 Mastoiditis & Related Conditions 37 13.41H71 Cholesteatoma of Middle Ear 2 0.72H72 Perforation of Tympanic Membrane 18 6.52H90 Conductive and Sensorineural Hearing Loss 2 0.72J04 Acute Laryngitis and Tracheitis 1 0.36J05 Acute Obstructive Laryngitis (Croup) & Epiglottitis 1 0.36J30 Vasomotor and Allergic Rhinitis 2 0.72J31 Chronic Rhinitis, Nasopharyngitis & Pharyngitis 3 1.09J32 Chronic Sinusitis 15 5.43J33 Nasal Polyp 3 1.09J34 Other & Unspecified Disorders of Nose and Nasal Sinuses 4 1.45J35 Chronic Disease of Tonsils and Adenoids 6 2.17J36 Peritonsillar Abscess 2 0.72J39 Other diseases of Upper Respiratory Tract 3 1.09J44 Other Chronic Obstructive Pulmonary Diseases 4 1.45J80 Acute Respiratory Distress Syndrome 2 0.72J96 Respiratory Failure 2 0.72J98 Other Respiratory Disorders 7 2.54K07 Dentofacial Anomalies 2 0.72K09 Cysts of Oral Region 1 0.36
Diagnosis of ENT Inpatients 
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The majority of sex distribution is male with 161 patients (58.3%). The length of stay was mainly for 4–6 days which was 120 data (43.4%). Based on  results on the study, 276 patients were divided into 61 types of diseases (Table 2). Mastoiditis is the disease with the highest number of patients, 37 patients (13.41%), followed by malignant neoplasm of paranasal sinus 18 patients (6.52%), tympanic membrane perforation 18 patients (6.52%), chronic sinusitis 15 patients (5.43%), and malignant neoplasm of larynx 14 patients (5.07%).The results showed that 273 patients (98.9%) used a single antibiotic (Table 3). Antibiotic changes were only carried out in 8 patients (2.9%). The antibiotics generally used for 2–3 days with 204 data (73.9%). 
Antibiotics were widely used with empirical + prophylactic indications as shown in 214 patients (77.5%). Majority of the antibiotics was administered via intravenous lines with 254 data (92%)Among 276 patients given antibiotics, there were 13 types of single antibiotics and combinations given (Table 4). Among13 types of antibiotics, there were 10 single antibiotics (99.4%) and 3 combinations of 2 antibiotics (0.06%). The most widely administered type of single antibiotic was cefazolin as many as 213 data (42.51%), ceftriaxone 148 data (29.54%), and cefotaxime 104 data (20.76%). The combination antibiotic used was a combination of ceftriaxone with cefotaxime, 
cotrimoxazole, and levofloxacin with the use of each 1 datum (0.2%).The use of antibiotics can be described 
more specifically based on the type of therapy which includes prophylaxis, empirical, and 
K12 Stomatitis and Related Lesions 5 1.81L02 Cutaneous Abscess, Furuncle & Carbuncle 1 0.36L92 Granulomatous Disorders of Skin & Subcutaneous Tissue 1 0.36M79 Other Soft Tissue Disorders 1 0.36
M95 Other Acquired Deformities of The Musculoskeletal System & Connective Tissue 3 1.09Q17 Other Congenital Malformation of Ear 2 0.72Q18 Other Congenital Malformations of Face & Neck 1 0.36S01 Open Wound of Head 1 0.36S02 Fracture of Skull and Facial Bones 8 2.9S08 Traumatic Amputation of Parts of Head 1 0.36S11 Open Wound of Neck 1 0.36T16 Foreign Body in Ear 1 0.36T17 Foreign Body in Respiratory Tract 3 1.09T18 Foreign Body in Alimentary Tract 13 4.71T81 Complications of Procedures 1 0.36Total 276 100
Table 3
 
Characteristic n %Drug prescribed   Single antibiotic 273 98.9   Combination of 2 antibiotic 3 1.1   Combination of  >2 antibiotic 0 0Antibiotic change   Yes 8 2.9   No 268 97.1Duration   1 day 15 5.4   2-3 days 204 73.9   4-7 days 36 13> 7 days 21 7.6Indication
   Definitive 7 2.5   Empirical 42 15.5   Prophylaxis 11 4
   Prophylaxis + Definitive 2 0.7   Prophylaxis + Empiric 214 77.5Route   Intravenous 254 92   Peroral 6 2.2   Intravenous + Peroral 16 5.8
Characteristic of Antibiotic Use 
(n=276)
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definitive therapy. The most commonly used antibiotic as prophylaxis was cefazolin with 210 data (92.51%), as empirical therapy was ceftriaxone with 139 data (52.65%), and as 
definitive therapy was ceftriaxone with 5 data (50%).Both culture and bacterial sensitivity tests were rarely carried out, only 13 patients (4.7%) were tested for culture and 7 patients (2.5%) were tested for bacterial sensitivity. Of the 13 patients, 21 samples were tested, 10 of which had no bacterial growth. There were 6 types of bacteria found, E. coli with 4 data (36.36%), S. 
epidermidis 1 data (9.09%), K. pneumoniae 1 data (9.09%), Pseudomonas aeruginosa 1 data (9.09%), A. baumannii 2 data (18.18%), and 
Aeromonas salmonicida 2 data (18.18%). The results of the bacterial sensitivity test can be seen (Table 6). E. coli is only sensitive to 7 of the 17 types of antibiotics tested. S. 
epidermidis is sensitive to 15 of the 19 types of antibiotics tested except chloramphenicol, 
ciprofloxacin, cotrimoxazole, and levofloxacin. 
K. pneumoniae is still sensitive to 13 of the 15 types of antibiotics tested. P. aeruginosa is still sensitive to amikacin, ceftazidime, 
ciprofloxacin, gentamicin, meropenem, and 
piperacillin/tazobactam. A. baumannii is only sensitive to amikacin, meropenem, piperacillin/tazobactam, tigecyclin, and trimethoprim-sulfamethoxazole. E. coli, 
P. aeruginosa, and A. baumannii isolates were resistant to cefazolin which was the most common antibiotic used in this study. Resistance was found to be higher against 
ampicillin, ciprofloxacin, and ceftriaxone and was rarely found in meropenem, amikacin, and tigecyclin.
Table 4 Distribution of Antibiotic Use 
Antibiotics
Definitive Empiric Prophylaxis Total
n % n % n % n %Single antibiotic   Amoxicillin 1 10 1 0.38 1 0.44 3 0.6   Cefadroxil 0 0 0 0 1 0.44 1 0.2   Cefazolin 1 10 2 0.76 210 92.51 213 42.51
   Cefixime 0 0 7 2.65 1 0.44 8 1.6   Cefotaxime 0 0 94 35.61 10 4.41 104 20.76   Ceftriaxone 5 50 139 52.65 4 1.76 148 29.54
   Ciprofloxacin 0 0 12 4.55 0 0 12 2.4   Co Amoxiclav 0 0 2 0.76 0 0 2 0.4
   Levofloxacin 1 10 4 1.52 0 0 5 1
   Ofloxacin 0 0 2 0.76 0 0 2 0.4Combination of antibiotic   Ceftriaxone + Cefotaxime 0 0 1 0.38 0 0 1 0.2   Ceftriaxone + Cotrimoxazole 1 10 0 0 0 0 1 0.2
   Ceftriaxone + Levofloxacin 1 10 0 0 0 0 1 0.2Total 10 100 264 100 227 100 501 100
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Table 5
Test n %Culture test   Tested 13 4.7   Not tested 263 95.3Bacterial sensitivity test   Tested 7 2.5   Not tested 269 97.5
Overview of Culture Tests and 
Bacterial Sensitivity Tests 
(n=276)
:39–47
44 International Journal of Integrated Health Sciences. 2019;7(1)
Table 6 Culture Test and Bacterial Sensitivity Tests Results (n=9) 
Organism 
(Number of 
Samples)
Antibiotics
Susceptible Intermediate Resistant
n % n % n %E. coli (4) Amikacin 4 100 0 0 0 0Ampicillin 0 0 0 0 2 50Ampicillin/Sulbactam 0 0 0 0 4 100Aztreonam 0 0 0 0 4 100Cefazolin 0 0 0 0 4 100Cefepime 0 0 0 0 4 100Ceftazidime 0 0 0 0 4 100Ceftriaxone 0 0 0 0 4 100
Ciprofloxacin 0 0 0 0 4 100Cotrimoxazol 1 25 0 0 1 25Ertapenem 2 50 0 0 0 0Gentamicin 0 0 0 0 4 100Meropenem 3 75 0 0 0 0Nitrofurantoin 1 25 1 25 0 0Piperacillin/Tazobactam 0 0 0 0 4 100Tigecyclin 4 100 0 0 0 0TMP-SMX* 1 25 0 0 1 25S. epidermidis (1) Amoxicillin/Clavulanate 1 100 0 0 0 0Ampicillin/Sulbactam 1 100 0 0 0 0Cefadroxil 1 100 0 0 0 0Cefazolin 1 100 0 0 0 0Cefepime 1 100 0 0 0 0
Cefixime 1 100 0 0 0 0Cefoperazon 1 100 0 0 0 0Cefotaxime 1 100 0 0 0 0Cefoxitin 1 100 0 0 0 0Ceftazidime 1 100 0 0 0 0Ceftriaxone 1 100 0 0 0 0Cefuroxime 1 100 0 0 0 0Chloramphenicol 0 0 0 0 1 100
Ciprofloxacin 0 0 0 0 1 100Cotrimoxazol 0 0 0 0 1 100Erythromycin 1 100 0 0 0 0Gentamicin 1 100 0 0 0 0
Levofloxacin 0 0 0 0 1 100Meropenem 1 100 0 0 0 0K. pneumonia (1) Amikacin 1 100 0 0 0 0
Pattern of Bacteria, Antibiotic Uses and Sensitivity among ENT Infectious Disease
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Ampicillin 0 0 0 0 1 100Ampicillin/Sulbactam 1 100 0 0 0 0Aztreonam 1 100 0 0 0 0Cefazolin 1 100 0 0 0 0Cefepime 1 100 0 0 0 0Ceftazidime 1 100 0 0 0 0Ceftriaxone 1 100 0 0 0 0
Ciprofloxacin 1 100 0 0 0 0Ertapenem 1 100 0 0 0 0Gentamicin 1 100 0 0 0 0Meropenem 1 100 0 0 0 0Nitrofurantoin 0 0 1 100 0 0Tigecyclin 1 100 0 0 0 0TMP-SMX* 1 100 0 0 0 0P. aeruginosa (1) Amikacin 1 100 0 0 0 0Ampicillin 0 0 0 0 1 100Ampicillin/Sulbactam 0 0 0 0 1 100Aztreonam 0 0 1 100 0 0Cefazolin 0 0 0 0 1 100Cefepime 0 0 1 100 0 0Ceftazidime 1 100 0 0 0 0Ceftriaxone 0 0 0 0 1 100
Ciprofloxacin 1 100 0 0 0 0Gentamicin 1 100 0 0 0 0Meropenem 1 100 0 0 0 0Nitrofurantoin 0 0 0 0 1 100Piperacillin/Tazobactam 1 100 0 0 0 0Tigecyclin 0 0 0 0 1 100TMP-SMX* 0 0 0 0 1 100A. Amikacin 2 100 0 0 0 0baumannii (2) Ampicillin 0 0 0 0 2 100Ampicillin/Sulbactam 0 0 0 0 2 100Aztreonam 0 0 0 0 2 100Cefazolin 0 0 0 0 2 100Cefepime 0 0 0 0 2 100Ceftazidime 0 0 0 0 2 100
Ciprofloxacin 0 0 0 0 2 100Gentamicin 0 0 0 0 2 100Meropenem 1 50 0 0 1 50Nitrofurantoin 0 0 0 0 2 100Piperacillin/Tazobactam 1 50 0 0 1 50
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DiscussionThe results of this study show that 273 patients (98.9%) were given a single antibiotic. Antibiotic changes were only carried out in 8 patients (2.9%). The majority of the duration of antibiotic use is 2–3 days with 204 data (73.9%). The indications of giving antibiotics mostly are for prophylactic and empirical purpose with 214 patients (77.5%). The most widely used route is 254 intravenous data (92%). There are 13 types of single antibiotics and combinations given, 10 single antibiotics (99.4%) and 3 combinations of 2 antibiotics (0.06%). The most common type used as single antibiotic was cefazolin with 213 data (42.51%). The combination antibiotic used is a combination of ceftriaxone with cefotaxime, 
cotrimoxazole, and levofloxacin with the use of each 1 data (0.2%). A similar study in India stated that 1797 patients (69.11%) were given a single antibiotic, 398 patients (49.56%) were given a combination of 2 antibiotics. The most frequently used routes are as many as 2699 data (74.99%). The most commonly prescribed antibiotics are beta-lactam groups of 2724 data (75.68%).10 The results of this study are in line with the study because single antibiotics were given more to patients and the antibiotics prescribed by the majority were beta-lactam groups. The possibility of the beta-lactam group is used because of its broad spectrum making it effective for curing infectious diseases.11 In both studies there were differences in the route of administration of the most commonly used antibiotics. This might happen because in the study the number of outpatients was more than inpatients, so that the oral route was more preferred.In this study, the most commonly used antibiotic as prophylaxis was cefazolin with 210 data (92.51%), as empirical therapy was ceftriaxone with 139 data (52.65%), and 
as definitive therapy was ceftriaxone with 5 data (50%). Other similar studies in the United States stated that antibiotics used as prophylaxis were 2230 data of ampicillin/sulbactam (25.2%), clindamycin 1431 data (14.2%), cefazolin + metronidazole 1220 data (13.8%), cefazolin 835 data (9.5%), and others 3210 data (35.3%).12 There are differences in prophylactic antibiotics used 
in both studies, but not significant because the majority use beta-lactam groups. Based on the Regulation of the Ministery of Health of the Republic of Indonesia Number 2406/MENKES/PER/XII/2011 About General Guidelines for the Use of Antibiotics, I and II generation cephalosporins are recommended 
for use as surgical prophylaxis.8 According to the American Academy of Otolaryngology-
Head and Neck Surgery, definitive therapy recommendations are adjusted to disease-causing organisms, but the most recommended are penicillin groups. Recommendations for empirical therapy may vary depends on the disease, but the majority recommended are beta-lactam groups (penicillins and cephalosporins).13 This indicates that the results of this study are in line with therapeutic recommendations because the majority of those used are ceftriaxone which is a beta-lactam group.In this study the culture and sensitivity tests were only carried out in a few patients, namely 13 patients (4.7%) who were tested for culture and 7 patients (2.5%) who were tested for bacterial sensitivity. There are 6 types of bacteria found, i.e., E. coli, S. epidermidis, 
K. pneumoniae, P. aeruginosa, A.baumannii, and Aeromonas salmonicida. Similar study conducted in Germany states that there are 6 types of bacteria found, i.e. S. pneumoniae, 
Moraxella Catarrhalis, Haemophillus 
influenzae, S. pyogenes, S. aureus, and P. 
aeruginosa. There is a type of bacteria found in both studies which is P. aeruginosa. The results of this study indicate that P. aeruginosa is still sensitive to amikacin, ceftazidime, 
ciprofloxacin, gentamicin, meropenem, and piperacillin/tazobactam. The results of this study were lower than the results of the study in Germany because in the study P. aeruginosa was still sensitive to all the antibiotics tested. This can occur because research in Germany uses more samples so the results are more diverse.14This study had several limitations such as many medical record data that were not stored in the MCI and the incomplete information contained in the medical record regarding the use of antibiotics, especially for indications of its use. Resistance had also begun to emerge so that the use of antibiotics must be re-evaluated to prevent such resistance from increasing. Suggestions for overcoming the limitations of this study are the writing of a complete medical record and conducting further research related to the pattern of antibiotic use, bacterial patterns and its sensitivity in the ENT department so that the results of the study can be discussed further.In summary, there are several types of antibiotic used in ENT Department and also pattern of bacteria and its sensitivity. Bacterial resistance can be prevented by giving proper antibiotics to the patients.
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